Operating cash flow increased 51.8%
Operating cash flow changed +51.8% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating cash flow changed +51.8% from the comparable as-filed period.
Shares outstanding changed +53.7% from the comparable as-filed period. The change ranks at the 62th percentile of 8 prior comparable changes.
Operating income changed -111.8% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Net income changed -111.6% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Research & development changed +186.0% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.